Benign Ovarian Mass

download Benign Ovarian Mass

of 39

Transcript of Benign Ovarian Mass

  • 8/11/2019 Benign Ovarian Mass

    1/39

    BENIGN OVARIAN MASS

    Dr. VIDHI CHAUDHARY

    ASSISTANT PROFESSOROBS& GYNAE, LHMC, DELHI.

  • 8/11/2019 Benign Ovarian Mass

    2/39

    Ovarian masses are a common finding.

    It is often difficult to clinicallydifferentiate between benign and

    malignant conditions

    Neoplasms constitute a significant

    number, and most are benign.

  • 8/11/2019 Benign Ovarian Mass

    3/39

    CLASSIFICATION

  • 8/11/2019 Benign Ovarian Mass

    4/39

    FUNCTIONAL OVARIAN CYSTS INCLUDES:

    a. Follicular cysts

    b. Corpus luteum cysts

    c. Theca luten cysts

    BENIGN OVARIAN NEOPLASM1. Serous cystadenoma

    2. Mucinous cystadenoma

    3. Endometrioma4. Dermoid cysts

    5. Fibroma

  • 8/11/2019 Benign Ovarian Mass

    5/39

    FUNCTIONAL CYSTS

    - disruption of normal ovulation & altered

    Angiogenesis

    - derive mass from accumulation of

    intrafollicular fluids rather than cellular

    proliferation

    - most common detected cysts in the

    reproductive age group

    - Usually asymptomatic

    - Resolve spontaneously.

    - surgical evaluation -required for persistent

    cysts.

  • 8/11/2019 Benign Ovarian Mass

    6/39

    FOLLICULAR CYSTS

    Follicular cysts -Hormonal dysfunction

    prior to ovulation results in expansion ofthe follicular antrum with serous fluid andformation of a follicular cyst.

  • 8/11/2019 Benign Ovarian Mass

    7/39

    CORPUS LUTEUM CYST

    Results from Hemorrhage inside a corpus luteum.

    "great imitators"

    Immediately following hemorrhage into its cavity,the cyst appears echogenic and mimics a solidmass.

    reticular pattern develop

    retracting clot -intramural nodule.

    transvaginal color Doppler -brightly colored ringbecause of increased surrounding vascularity k/ar ing of f i re.

  • 8/11/2019 Benign Ovarian Mass

    8/39

    Theca luteal cysts

    Result from over stimulation of theovary by HCG.

    Common in molar pregnancy,choriocarcinoma, IVF pregnancy

  • 8/11/2019 Benign Ovarian Mass

    9/39

    Risk Factors

    Smoking- changes in gonadotropin

    secretion and ovarian function .

    progestin-only contraceptives

    Tamoxifen- 15 to 30 percent

  • 8/11/2019 Benign Ovarian Mass

    10/39

    Symptoms

    Asymptomatic.

    Symptoms -pain and vague pressuresensations are common.

    acute severe pain ruptured corpus

    luteum with hemorrhage.

  • 8/11/2019 Benign Ovarian Mass

    11/39

    Diagnoses

    Pelvic examination-

    mobile, cystic, nontender, and foundlateral to the uterus

    Transvaginal Scan-rounded anechoiclesions with thin, regular walls

    TUMOR MARKERS- Detection of serumbeta hCG to differentiate ectopicpregnancy or a corpus luteum ofpregnancy

  • 8/11/2019 Benign Ovarian Mass

    12/39

    Follicular cyst

    smooth walls and lack of internal echoes.

  • 8/11/2019 Benign Ovarian Mass

    13/39

    Diffuse low level echoes

  • 8/11/2019 Benign Ovarian Mass

    14/39

    Reticular interfaces :resolving

    hemorrhagic cyst

  • 8/11/2019 Benign Ovarian Mass

    15/39

    Theca lutein cysts

  • 8/11/2019 Benign Ovarian Mass

    16/39

    Management

    Observation -spontaneously regress within6 months of identification.

    Post menopausal-sonographic evidence of

    1. thin-walled, unilocular cyst

    2. (2) cyst diameter less than 5 cm

    3. (3) no cyst enlargement duringsurveillance

    4. (4) normal serum CA125 levels

  • 8/11/2019 Benign Ovarian Mass

    17/39

    Management

    OCP- unclear role.

    Surgical Excision - persistent cysts & >3 cm &> 5cm

    diameter(premenopausal&

    postmenopausal respectively)

    Laparoscopic cystectomy.

  • 8/11/2019 Benign Ovarian Mass

    18/39

    Benign Neoplastic Ovarian

    CystsMost common :

    serous and mucinous cystadenomas(surface epithelial neoplasia group)

    mature cystic teratomas (germ cell)

  • 8/11/2019 Benign Ovarian Mass

    19/39

    Serous cystadenoma-

    5% to 10% -borderline malignant potential

    20% to 25% are malignant.

    multilocular, with papillary components. The surface epithelial cells secrete serous

    fluid, resulting in a watery cyst content.Psammoma bodies, (areas of fine calcific

    granulation), if present can be seen onradiograph.

  • 8/11/2019 Benign Ovarian Mass

    20/39

    Mucinous ovarian tumors-

    grow to largesize.

    bilateral in 10% . 5-10% are malignant.

    They have lobulated, smooth surface,

    multilocular, . Mucoid material ispresent within the cystic loculations . It

    is difficult to distinguish histologically

    from metastatic gastrointestinal

    malignancies.

  • 8/11/2019 Benign Ovarian Mass

    21/39

  • 8/11/2019 Benign Ovarian Mass

    22/396,810 grams, 20 cm X 40

    Benign serous

    cystadenoma

  • 8/11/2019 Benign Ovarian Mass

    23/39

    Teratoma

    Teratomas arise from a single germ cell.

    can contain any of the three germlayersectoderm, mesoderm, or

    endoderm.

    Types

    a. mature b.immature

  • 8/11/2019 Benign Ovarian Mass

    24/39

    Mature teratoma

    benign tumor

    mature forms of the three germ celllayers

    (1) Mature cystic teratomas /benign

    cys t ic teratoma /dermo id cyst

    (2) Mature solid teratomas-elements

    formed into a solid mass

  • 8/11/2019 Benign Ovarian Mass

    25/39

    Mature teratoma

    (3) Fetiform teratomas orhomunculus.

    (4) Monodermal teratoma-composed

    one highly specialized tissue type.

    Eg.thyroid tissue are termed st ruma

    ovar i i.

  • 8/11/2019 Benign Ovarian Mass

    26/39

    b. immature -This neoplasm is

    malignant. Immature tissues from one,

    two, or all three germ cell layers are

    found and frequently coexist with

    mature element.

  • 8/11/2019 Benign Ovarian Mass

    27/39

    Mature cystic teratomas

    peak incidence -20 to 40 years ,pregnancy.

    bilateral -10 percent .

    10 to 25 percent of all ovarian neoplasms

    60 percent of all benign ovarian

    neoplasms

    Malignant transformation -1 to 3 percent-

    most common squamous cell carcinoma

    80%, sarcoma

  • 8/11/2019 Benign Ovarian Mass

    28/39

    Mature cystic teratomas

    PathologySmooth walled,unilocular

    with an area of localized growth that

    protrudes into the cystic cavity.

    Inner surface has a localized nodule, k/a

    Rokitansky protuberance, composed of

    adipose tissue (embryonal node)

    Hair and fatty secretions +

    Tumor Origin-genetic material

    contained within a single oocyte

  • 8/11/2019 Benign Ovarian Mass

    29/39

    Diagnosis

    Tip of the iceberg"echogenic interfaces offat, hair, and tissues in focus that shadowand thus obscure structures behind it.

    Fat-fluid or hair-fluid levelslineardemarcation where serous fluid interfaceswith sebum or hair.

    Hairlines and dots. Rokitansky protuberancehyperechoic, and

    creates an acute angle with the cyst wall.

  • 8/11/2019 Benign Ovarian Mass

    30/39

  • 8/11/2019 Benign Ovarian Mass

    31/39

    Mature cystic teratomas

  • 8/11/2019 Benign Ovarian Mass

    32/39

    Complications

    -15 percent torsion.

    -cyst rupture (rare)- acute granulomatusperitonitis

  • 8/11/2019 Benign Ovarian Mass

    33/39

    Other benign tumors

    Fibromas(a focus of stromal cells)-

    associated with Meigs syndrome (pleural

    effusion with benign pelvic tumors)

    Pseudo-Meigssyndrome consists of

    pleural effusion ,ascites, and benign

    tumors of the ovary other than fibromas.tumors of the fallopian tube or uterus

    ,mature teratomas and struma ovarii.

  • 8/11/2019 Benign Ovarian Mass

    34/39

    Treatment

    SURGICAL EXCISION

    -definitive diagnosis, affords relief of

    symptoms, and prevents complications oftorsion, rupture, and malignantdegeneration.

    ROUTE-laparoscopic or laparotomy/ minilap

    LAPROSCOPY -increased rates of cystrupture with the risk for tumor spill andmalignant seeding .

  • 8/11/2019 Benign Ovarian Mass

    35/39

    Treatment

    Surgery influenced by lesion size, age,

    and intraoperative findings

    -cystectomy preservation of

    reproductive function

    -oophorectomy- postmenopausal women

    -Staging -Clinical findings of malignancy

  • 8/11/2019 Benign Ovarian Mass

    36/39

    RADIOLOGICAL FEATURES OF BENIGN

    OVARIAN MASSES:

    1. Unilocular

    2. Smooth surface

    3. No solid elements4. No external or internal outgrowth

    5. No ascites

    6. Unilateral

    7. Normal doppler flow

  • 8/11/2019 Benign Ovarian Mass

    37/39

    CA-125 in:

    Leiomyoma

    Endometriosis/adenomyosis

    PID

    Pregnancy

    Malignancies-lung, breast, colon

    Pancreatitis

    Cirrhosis

  • 8/11/2019 Benign Ovarian Mass

    38/39

    i

  • 8/11/2019 Benign Ovarian Mass

    39/39

    E ith li l i t

    ovarian

    capsule